Novavax (NVAX) Operating Income (2010 - 2026)
Novavax's Operating Income was -$54.91 million in Q2 2026, compared with $101.07 million a year earlier.
Powered by 
Analysis
Novavax (NVAX) Operating Income (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Novavax's Operating Income was -$234.12 million through Jun 30, 2026; for FY2025, it was $452.8 million.
- In earlier years, Operating Income was -$248.93 million in FY2024, -$566.51 million in FY2023, -$644.74 million in FY2022 and -$1.69 billion in FY2021.
- Quarterly Operating Income has moved between -$824.97 million (Q4 2021) and $515.51 million (Q1 2025) over five years.
- Per Business Quant data, NVAX's Operating Income in the three quarters before Q2 2026 was -$15.43 million (Q1 2026), $14.23 million (Q4 2025) and -$178.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Novavax | 1.72 Bn | -1.28 Bn | 42.45 Mn | -54.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -54.91 Mn |
| Mar 31, 2026 | -15.43 Mn |
| Dec 31, 2025 | 14.23 Mn |
| Sep 30, 2025 | -178.02 Mn |
| Jun 30, 2025 | 101.07 Mn |
| Mar 31, 2025 | 515.51 Mn |
| Dec 31, 2024 | -131.08 Mn |
| Sep 30, 2024 | -134.02 Mn |
| Jun 30, 2024 | 161.00 Mn |
| Mar 31, 2024 | -144.83 Mn |
| Dec 31, 2023 | -183.57 Mn |
| Sep 30, 2023 | -125.63 Mn |
| Jun 30, 2023 | 55.46 Mn |
| Mar 31, 2023 | -312.77 Mn |
| Dec 31, 2022 | -243.88 Mn |
| Sep 30, 2022 | -127.19 Mn |
| Jun 30, 2022 | -482.96 Mn |
| Mar 31, 2022 | 209.29 Mn |
| Dec 31, 2021 | -824.97 Mn |
| Sep 30, 2021 | -307.14 Mn |
API Access
Novavax Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();